Research is being conducted on respiratory syncytial virus (RSV) risk factors across different age groups, from infants to older adults. The severity and impact of RSV infection, as well as strategies for prevention, including vaccines and antibody therapies, are being studied. Findings suggest that RSV can have a significant impact on infants, particularly those under six months, and may also affect other age groups, with various factors influencing the severity of infection.